4//SEC Filing
CAUWENBERGH GEERT 4
Accession 0001209191-19-014816
CIK 0001533040other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:24 AM ET
Size
5.9 KB
Accession
0001209191-19-014816
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2019-02-28$0.38/sh+152,415$57,887→ 481,592 total
Holdings
- 450(indirect: By Spouse)
Common stock, $0.0001 par value
Footnotes (1)
- [F1]As reported on the Current Report on Form 8-K filed on February 15, 2019, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on February 28, 2019, the reporting person received a total of 152,415 shares of common stock from the Company in lieu of $57,887 of cash compensation, which includes a portion of the reporting person's deferred annual bonus for 2018 that was payable on such date.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001285648
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 9:24 AM ET
- Size
- 5.9 KB